The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

被引：0
|
作者：
Shabbir, S. [1 ]
Pouliquen, I. [2 ]
Bentley, J. H. [3 ]
Bradford, E. S. [4 ]
Kaisermann, M. C. [5 ]
Albayaty, M. [6 ]
机构：
[1] GSK, Clin Platforms & Sci PCPS, Global Clin Sci & Delivery GCSD R&D Projects, Stevenage, Herts, England
[2] GSK, Clin Pharmacol Modelling & Simulat, Uxbridge, Middx, England
[3] GSK, Clin Stat, Uxbridge, Middx, England
[4] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[5] GSK, Resp Therapy Area, Collegeville, PA USA
[6] Northwick Pk Hosp & Clin Res Ctr, PAREXEL Early Phase Clin Unit, Harrow, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1311
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial
    Shabbir, Shaila
    Pouliquen, Isabelle J.
    Bentley, Jane H.
    Bradford, Eric S.
    Kaisermann, Morrys C.
    Albayaty, Muna
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (03): : 375 - 385
  • [2] The pharmacokinetics and relative bioavailability of mepolizumab 100 mg liquid formulation administered subcutaneously to healthy participants: A randomized trial
    Shabbir, Shaila
    Pouliquen, Isabelle
    Bentley, Jane
    Bradford, Eric
    Kaisermann, Morrys
    Albayaty, Muna
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1180 - 1181
  • [3] Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects
    Cai, Wendy
    Chen, Cecil
    Zhong, Z. John
    Freimuth, William W.
    Lewis, William
    Subich, David
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S267 - S267
  • [4] Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects
    Cai, Wendy W.
    Fiscella, Michele
    Chen, Cecil
    Zhong, Z. John
    Freimuth, William W.
    Subich, David C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 349 - 357
  • [5] Pharmacokinetics and safety of daptomycin administered subcutaneously in healthy volunteers: a single-blinded randomized crossover trial
    Maurille, Charles
    Baldolli, Aurelie
    Creveuil, Christian
    Parienti, Jean-Jacques
    Michon, Jocelyn
    Peyro-Saint-Paul, Laure
    Brucato, Sylvie
    Dargere, Sylvie
    Comets, Emmanuelle
    Verdier, Marie-Clemence
    Verdon, Renaud
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (11) : 3016 - 3022
  • [6] The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers
    Noehr-Jensen, Lene
    Damkier, Per
    Bidstrup, Tanja Busk
    Pedersen, Rasmus Steen
    Nielsen, Flemming
    Brosen, Kim
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 437 - 445
  • [7] The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers
    Lene Noehr-Jensen
    Per Damkier
    Tanja Busk Bidstrup
    Rasmus Steen Pedersen
    Flemming Nielsen
    Kim Brosen
    European Journal of Clinical Pharmacology, 2006, 62 : 437 - 445
  • [8] Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects
    Struemper, Herbert
    Murtaugh, Thomas
    Gilbert, Jane
    Barton, Matthew E.
    Fire, Joseph
    Groark, James
    Fox, Norma Lynn
    Roth, David
    Gordon, David
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (03): : 208 - 215
  • [9] The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen, L.
    Damkier, P.
    Bidstrupl, T. B.
    Pedersen, R. S.
    Nielsen, F.
    Brosen, K.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 221 - 221
  • [10] A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
    van Rossem, Koen
    Lowe, Jenny A.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 23 - 31
12345